GlassScriptPhysician profile
Vanessa R Erickson
NPI 1700072659
$1,713.66
in general payments reported to CMS, 2019-2025
15 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $45.51 · 2022: $89.95 · 2023: $223 · 2024: $250 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $588.77 | 2019 | |
| Neurent Medical Limited | $200.76 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Genzyme Corporation | $177.02 | 2023 | |
| Smith+Nephew, INC. | $158.18 | 2020-2025 | Halo, Tula |
| Inspire Medical Systems, INC. | $111.86 | 2025 | Inspire |
| Alk-Abello, INC | $96.20 | 2019 | |
| Aerin Medical INC. | $86.13 | 2019-2022 | |
| Intersect Ent, INC. | $63.02 | 2019 | |
| Glaxosmithkline, LLC. | $57.93 | 2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $52.33 | 2022-2024 | Dupixent |
| Integra Lifesciences Corporation | $32.29 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Ars Pharmaceuticals Operations, INC. | $29.78 | 2025 | Neffy |
| Stryker Corporation | $26.20 | 2019 | |
| Cook Medical LLC | $18.22 | 2019 | |
| Medline Industries LP | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.